ABVC BioPharma, Inc. Common Stock
Symbol: ABVC (NASDAQ)
3.15
▲ (0.96%) 0.030
Company Description:
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Key Stats
- Today's Open: $3.05
- Today's High: $3.237
- Today's Low: $3.036
- Today's Volume: 89.61K
- Yesterday Close: $3.12
- Yesterday High: $3.23
- Yesterday Low: $3.04
- Yesterday Volume: 103.26K
- Last Min Volume: 4
- Last Min High: $3.15
- Last Min Low: $3.15
- Last Min VWAP: $3.15
Company Profile
- Name: ABVC BioPharma, Inc. Common Stock
- Website: https://www.abvcpharma.com
- Listed Date: 2004-11-09
- Location: FREMONT, CA
- Market Status: Active
- CIK Number: 0001173313
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $73.45M
- Round Lot: 100
- Outstanding Shares: 23.54M
- Asset Type: CS
RECENT FILINGS FOR ABVC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-12 | 8-K/A | View |
| 2025-08-15 | 424B4 | View |
| 2025-08-15 | 424B4 | View |
| 2025-08-15 | 424B4 | View |
| 2025-08-15 | 424B4 | View |
| 2025-08-15 | 424B4 | View |
| 2025-08-14 | 8-K | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-13 | 10-Q | View |
| 2025-07-18 | 8-K/A | View |
| 2025-07-15 | SCHEDULE 13D/A | View |
| 2025-06-27 | S-8 | View |
| 2025-06-04 | 8-K | View |
| 2025-06-03 | SCHEDULE 13D | View |
| 2025-05-30 | 8-K/A | View |
| 2025-05-27 | POS AM | View |
| 2025-05-27 | POS AM | View |
| 2025-05-27 | POS AM | View |
| 2025-05-22 | S-3 | View |
| 2025-05-20 | EFFECT | View |
Latest News on ABVC